Navigation Links
Biocartis Strengthens Management Team With Chief Commercial Officer
Date:9/4/2013

LAUSANNE, Switzerland and MECHELEN, Belgium, September 4, 2013 /PRNewswire/ --


Biocartis, a molecular diagnostics company, announces today that Ulrik Cordes has joined the company as Chief Commercial Officer (CCO). Ulrik Cordes is an executive with 18+ years of experience in marketing and sales in the med-tech, pharma and biotech industry, of which the past 10 years in top level management roles.

"We are delighted to welcome Ulrik to Biocartis' Executive Team," said RudiPauwels, CEO and Chairman  of Biocartis. "We are transforming from a development company into a commercial business. The addition of Ulrik will be key to achieving our ultimate goal to making personalized medicine a day-to- day reality by building a global business. Ulrik possesses a unique combination of experience and success in building winning commercial strategies and attracting world class sales and sales support professionals."

Ulrik Cordes joins Biocartis most recently from Thermo Fisher Scientific, where he held the position of Global Sales & Marketing Director Slides & Specialty Glass since March 2012. Since 2002 Ulrik worked at DAKO A/S - A World-leading Company in Cancer Diagnostics, where he held a number of positions with increasing responsibility, most recently as Vice President Marketing Operations and Vice President Asia Pacific & Export Region.

He started his career in 1995 in Pharmacia Biotech A/S (now part of GE Healthcare). Ulrik received his Master of Science in Biochemistry from the University of Copenhagen and holds a Bachelor of Commerce (HD) from Copenhagen Business School.

About Biocartis (http://www.biocartis.com)
Biocartis aims to improve healthcare outcomes by enabling the practice of personalized medicine anywhere, anytime. Biocartis' ambition is to establish a new gold standard in diagnostic testing. Biocartis' innovative research and diagnostic systems are characterized by multiplex detection and simplified workflows which require less hands-on time and minimize sample requirements (especially for tumor biopsies). Additionally, Biocartis develops assays which have high clinical utility and compelling health economic value. Oncology is the primary focus of Biocartis as this is one of the greatest unmet needs for personalized medicine. Biocartis is well suited to address the growing need for individualized diagnosis and treatment of cancer patients.

Biocartis is a rapidly growing company; to date Biocartis staff includes over 170 people.


'/>"/>
SOURCE Biocartis NV
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Biocartis versterkt managementteam met commercieel directeur
2. CareFusion Strengthens U.K. Presence With Acquisition of Medical Products Distributor
3. Tris Pharma Expands Manufacturing Capacity and Strengthens Supply Chain to Support New and Pending Approvals
4. RxAlly Strengthens Leadership Team With New Chief Information Officer Mike Groh
5. PAREXEL Strengthens Outcomes Research Capabilities To Help Biopharma Meet Commercialization Goals
6. Actinium Pharmaceuticals Strengthens Management Team
7. Pharmalink AB Strengthens Senior Management Team
8. Jardogs Strengthens Leadership Team with the Addition of Two Seasoned Healthcare Executives
9. inVentiv Health Strengthens Clinical Leadership Team
10. Alliqua Strengthens and Realigns Executive Team
11. Neuland Labs Strengthens Commitment to Japanese Market With New Manufacturing Collaboration With Mitsubishi Healthcare Unit API Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/10/2017)... , Aug. 10, 2017  Physical Rehabilitation Network (PRN), ... in Lakewood, Colorado . The reputable clinic ... Lipkin , PT, DPT with his staff of four clinicians. ... of Pittsburgh and brings over 10 years of experience with ... Belmar PT marks the 10th PRN clinic in and ...
(Date:8/8/2017)... Aug. 8, 2017   ... diluted (GAAP) loss per share from continuing operations ... revenues increased 16 percent to $110 million ... 27 percent to $161 million ... from continuing operations increased 8 percent to $0.93 ...
(Date:8/7/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global ... Directors has approved the payment of a quarterly cash dividend ... The cash dividend of $0.24 per ... to stockholders of record as of the close of business ... to approval of the Board of Directors and may be ...
Breaking Medicine Technology:
(Date:8/21/2017)... Aliso Viejo, CA (PRWEB) , ... August 21, 2017 , ... ... Pixel Film Studios. Editors can quickly and easily add washed color grades to ... an image. The LUT changes every pixel’s color to the corresponding color indicated by ...
(Date:8/21/2017)... (PRWEB) , ... August 21, 2017 , ... Five chefs ... and awareness for Alzheimer’s Family Center. , Guests will be able to vote ... Beach Plaza, Braised Lamb Shank with Fennel Dill Salad, Feta Cheese Sauce & Garlic ...
(Date:8/21/2017)... ... August 21, 2017 , ... Duncan Insurance Agency ... the people of Michigan. The new initiative fundraises for the Kalamazoo Humane Society ... forefront of animal protection and welfare by addressing the root causes of pet ...
(Date:8/21/2017)... ... August 21, 2017 , ... PIXACORE , an independent full-service agency ... Top 100 agencies of the year by MM&M. , This is the first time ... important milestone for the agency. PIXACORE’s newfound recognition reflects its steady trajectory of ...
(Date:8/21/2017)... ... August 21, 2017 , ... San Diego physician and surgeon ... reform plan, has announced his candidacy for the 52nd Congressional District currently held by ... America’s Promise. Coming to this country at age eleven after suffering homelessness and hardship ...
Breaking Medicine News(10 mins):